A5006452215- Renal cell carcinoma treatment
- Bladder and Urothelial Cancer Treatments
- Renal and related cancers
- Multiple and Secondary Primary Cancers
- Renal and Vascular Pathologies
- Urinary and Genital Oncology Studies
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urological Disorders and Treatments
- Pediatric Urology and Nephrology Studies
- Inflammatory Bowel Disease
- Microscopic Colitis
- Minimally Invasive Surgical Techniques
- Urologic and reproductive health conditions
- Chronic Kidney Disease and Diabetes
- Genital Health and Disease
- Radiomics and Machine Learning in Medical Imaging
- Organ Donation and Transplantation
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Ferroptosis and cancer prognosis
- Urinary Bladder and Prostate Research
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- MRI in cancer diagnosis
British Columbia Children's Hospital
2016-2024
Saint Louis University
2018-2024
Saint Louis University Hospital
2018-2024
University of British Columbia
2019-2024
UCLouvain Saint-Louis Brussels
2022-2024
University of Nebraska at Omaha
2024
University of California, San Diego
2016-2021
New York Proton Center
2020
La Jolla Alcohol Research
2016-2020
Saint Louis Zoo
2019
Urothelial carcinoma of the bladder invasive into lamina propria on biopsy or transurethral resection tumor, termed “T1” disease, progresses to muscularis invasion in a subset patients. Prior studies have proposed histopathologic metrics predict progression, although methods vary widely and it is unclear which method most robust. This poses challenge since recent World Health Organization American Joint Commission Cancer editions encourage some attempt substratify T1 disease. To address this...
Objective To describe the utilization and compare quality outcomes of partial nephrectomy ( PN ) for cT 1a, 1b 2a renal masses using a large national database. Methods We conducted retrospective analysis patients from US National Cancer Database who underwent 1a/ 1b/T2a cell carcinoma between 2004 2013. examined use over time assessed indicators [positive surgical margin PSM 30‐day postoperative readmission rates]. Multivariable was to determine predictors outcome comparisons. Results A...
PURPOSE Previous studies have noted increased utilization of perioperative chemotherapy over time. The goal this study was to determine trends in use within a contemporary population. MATERIALS AND METHODS National Cancer Database queried for patients diagnosed with cT2-4N0M0 urothelial muscle invasive bladder cancer from 2011 2015 and underwent subsequent radical cystectomy. We retrospectively analyzed factors associated evaluated overall treatment the neoadjuvant adjuvant chemotherapy....
BACKGROUND: The impact of positive surgical margins (PSM) on outcomes in partial nephrectomy (PN) is controversial. We investigated PSM for patients undergoing PN overall survival (OS) different stages renal cell carcinoma (RCC).METHODS: Retrospective analysis from the US National Cancer Database who underwent cT1a-cT2b N0M0 RCC between 2004-13. Patients were stratified by pathological stage (pT1a, pT1b, pT2a, pT2b, and pT3a [upstaged]) analyzed margin status. Cox Regression multivariable...
Abstract Objectives Upper gastrointestinal (UGI) tract involvement is frequently reported in pediatric Crohn disease (CD) and ulcerative colitis (UC). Aside from granulomas, most findings are nonspecific. The aims of this study were to review the prevalence UGI patients with CD or UC at diagnosis describe differences endoscopic histologic features. Methods Patients aged 2 17 years diagnosed between 2000 2015 who had upper lower endoscopy randomly chosen BC Children’s Hospital inflammatory...
BackgroundInflammatory bowel disease (IBD) incidence is increasing among low-risk populations. This study examined a cohort of Canadian South Asian (SA) children with IBD to determine if their course differed from non-SA (NSA) children.
No AccessJournal of UrologyAdult Urology1 Jan 2017Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining Antiplatelet Therapy Timothy Ito, Ithaar H. Derweesh, Serge Ginzburg, Philip Abbosh, Omer A. Raheem, Hossein Mirheydar, Zachary Hamilton, David Y.T. Chen, Marc C. Smaldone, Richard E. Greenberg, Rosalia Viterbo, Alexander Kutikov, and Robert G. Uzzo ItoTimothy Ito Department Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania ,...